HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo Co. PLC

www.perrigo.com

Latest From Perrigo Co. PLC

Corporate Affairs: Biopharma’s First Line Of Defense Against Scrutiny

Amgen’s Judy Gawlik Brown is using her finance and consumer health background to make the big biotech’s message more authentic and accessible – a brisk reset against today’s disconnected world of alternative facts.

C-Suite Speaks Leadership

Meet The Quitters: Perrigo Profiles NRT Users To Help UK Pharmacists Drive OTC Smoking Cessation Sales

To coincide with Stoptober, Perrigo is extending its pharmacy-focused UK marketing strategy for leading smoking cessation brand NiQuitin with research-based sales advice for pharmacists centered on five types of "quitter."
Health OTC Drugs

Lupin’s ProAir Rival Has 'Moved Ahead' Despite CRL

Lupin is staring at stretched launch timelines in the US for its generic ProAir following a Complete Response Letter, but the company maintains that its application has progressed and the market opportunity for the product remains attractive.

Regulation Generic Drugs

US Setback For Lupin’s GxProAir But Application Has 'Moved Ahead'

Lupin is staring at stretched launch timelines in the US for its generic ProAir following a Complete Response Letter, but the company maintains that its application has progressed and the market opportunity for the product remains attractive.

Policy & Regulation India
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register